LIVIVO - The Search Portal for Life Sciences

zur deutschen Oberfläche wechseln
Advanced search

Search results

Result 1 - 10 of total 34

Search options

  1. Article ; Online: In treatment-resistant major depression, ketamine was noninferior to ECT for treatment response.

    Holsinger, Tracey / Riordan, Paul

    Annals of internal medicine

    2023  Volume 176, Issue 9, Page(s) JC105

    Abstract: Source citation: Anand A, Mathew SJ, Sanacora G, et al. ...

    Abstract Source citation: Anand A, Mathew SJ, Sanacora G, et al.
    MeSH term(s) Humans ; Ketamine/therapeutic use ; Depression ; Depressive Disorder, Major/drug therapy
    Chemical Substances Ketamine (690G0D6V8H)
    Language English
    Publishing date 2023-09-05
    Publishing country United States
    Document type Journal Article ; Comment
    ZDB-ID 336-0
    ISSN 1539-3704 ; 0003-4819
    ISSN (online) 1539-3704
    ISSN 0003-4819
    DOI 10.7326/J23-0068
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  2. Article ; Online: Circulating Tumor HPV DNA for Surveillance of HPV-Positive Oropharyngeal Squamous Cell Carcinoma: A Narrative Review.

    Lang Kuhs, Krystle A / Brenner, J Chad / Holsinger, F Chris / Rettig, Eleni M

    JAMA oncology

    2023  Volume 9, Issue 12, Page(s) 1716–1724

    Abstract: ... incidence of HPV-positive oropharyngeal squamous cell carcinoma and concomitant expansion of biomarker ... However, caution is advised; it is not yet known whether biomarker-based surveillance is truly beneficial, and ... Using Margaret Pepe's classic 5 phases of biomarker development for early detection of cancer ...

    Abstract Importance: Human papillomavirus (HPV)-positive oropharyngeal squamous cell carcinoma has an overall favorable prognosis, yet a subset of patients will experience devastating disease recurrence. Current surveillance standards for detection of recurrent disease are imperfect. There is growing interest in improving detection of recurrent disease through the use of plasma-based assays able to detect circulating tumor HPV DNA.
    Observations: Although most circulating tumor HPV DNA assays remain in the research domain, the circulating tumor tissue-modified viral HPV DNA assay became commercially available in the United States in early 2020 and has been increasingly used in the clinical setting. With the rapidly increasing incidence of HPV-positive oropharyngeal squamous cell carcinoma and concomitant expansion of biomarker capabilities for this disease, it is critical to reexamine current posttreatment surveillance practices and to determine whether emerging technologies may be used to improve outcomes for a growing survivor population. However, caution is advised; it is not yet known whether biomarker-based surveillance is truly beneficial, and as is true with any intervention, it has the capacity to cause harm.
    Conclusions and relevance: Using Margaret Pepe's classic 5 phases of biomarker development for early detection of cancer as a framework, this article reviews the current state of knowledge, highlights existing knowledge gaps, and suggests research that should be prioritized to understand the association between biomarker-based surveillance and patient outcomes. Specific attention is paid to the commercially available tumor tissue-modified viral HPV DNA assay, given its increasing clinical use. This review may serve as a road map for future research and a guide for clinicians considering its adoption in practice. Enrollment of patients into clinical trials incorporating biomarker-based surveillance should be prioritized.
    MeSH term(s) Humans ; Squamous Cell Carcinoma of Head and Neck ; Oropharyngeal Neoplasms/pathology ; Papillomavirus Infections ; Neoplasm Recurrence, Local ; Head and Neck Neoplasms ; Biomarkers ; DNA, Viral ; Papillomaviridae/genetics
    Chemical Substances Biomarkers ; DNA, Viral
    Language English
    Publishing date 2023-10-12
    Publishing country United States
    Document type Review ; Journal Article
    ISSN 2374-2445
    ISSN (online) 2374-2445
    DOI 10.1001/jamaoncol.2023.4042
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  3. Article: Rapid relief of severe major depressive disorder by use of preoperative ketamine and electroconvulsive therapy.

    Goforth, Harold W / Holsinger, Tracey

    The journal of ECT

    2007  Volume 23, Issue 1, Page(s) 23–25

    Abstract: Major depressive disorder is a difficult-to-treat and recurrent debilitating disorder. All approved somatic treatments for major depression to date require a significant time lapse before demonstrating an antidepressant effect. However, emerging evidence ...

    Abstract Major depressive disorder is a difficult-to-treat and recurrent debilitating disorder. All approved somatic treatments for major depression to date require a significant time lapse before demonstrating an antidepressant effect. However, emerging evidence indicates a potential role for the use of ketamine to rapidly relieve symptoms of major depression. We present a case of severe, recurrent major depressive disorder that demonstrated marked improvement within 8 hours of receiving a preoperative dose of ketamine and 1 treatment of electroconvulsive therapy with bitemporal electrode placement. This case is supportive of a role of ketamine in relieving symptoms of major depressive disorder rapidly and safely.
    MeSH term(s) Combined Modality Therapy ; Depressive Disorder, Major/drug therapy ; Depressive Disorder, Major/therapy ; Electroconvulsive Therapy ; Excitatory Amino Acid Antagonists/therapeutic use ; Humans ; Ketamine/therapeutic use ; Male ; Middle Aged ; Recurrence
    Chemical Substances Excitatory Amino Acid Antagonists ; Ketamine (690G0D6V8H)
    Language English
    Publishing date 2007-03
    Publishing country United States
    Document type Case Reports ; Journal Article
    ZDB-ID 1426385-3
    ISSN 1533-4112 ; 1095-0680
    ISSN (online) 1533-4112
    ISSN 1095-0680
    DOI 10.1097/01.yct.0000263257.44539.23
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  4. Article ; Online: St John's for depression, worts and all.

    Williams, John W / Holsinger, Tracey

    BMJ (Clinical research ed.)

    2005  Volume 330, Issue 7500, Page(s) E350–1

    MeSH term(s) Antidepressive Agents, Second-Generation/therapeutic use ; Depressive Disorder/drug therapy ; Double-Blind Method ; Humans ; Hypericum ; Nonprescription Drugs ; Paroxetine/therapeutic use ; Phytotherapy/methods ; Randomized Controlled Trials as Topic
    Chemical Substances Antidepressive Agents, Second-Generation ; Nonprescription Drugs ; Paroxetine (41VRH5220H)
    Language English
    Publishing date 2005-05-14
    Publishing country England
    Document type Editorial
    ZDB-ID 1362901-3
    ISSN 1756-1833 ; 0959-8154 ; 0959-8146 ; 0959-8138 ; 0959-535X ; 1759-2151
    ISSN (online) 1756-1833
    ISSN 0959-8154 ; 0959-8146 ; 0959-8138 ; 0959-535X ; 1759-2151
    DOI 10.1136/bmj.330.7500.E350
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  5. Article ; Online: Acceptability of dementia screening in primary care patients.

    Holsinger, Tracey / Boustani, Malaz / Abbot, David / Williams, John W

    International journal of geriatric psychiatry

    2011  Volume 26, Issue 4, Page(s) 373–379

    Abstract: Objectives: To determine the acceptability of dementia screening in two populations of older adults in different primary care settings.: Methods: Cross-sectional study of consecutive patients presenting for primary care appointments in the Duke ... ...

    Abstract Objectives: To determine the acceptability of dementia screening in two populations of older adults in different primary care settings.
    Methods: Cross-sectional study of consecutive patients presenting for primary care appointments in the Duke University Health System (n = 152) or Durham VA Medical Center (n = 193) were evaluated face to face using the Dementia Screening and Perceived Harms (SAPH) questionnaire.
    Results: Overall, 81% of primary care patients indicated that they would want to be screened to determine if they are developing dementia. After exposure to possible risks and benefits of screening, 86% of patients indicated they would like to be screened. The SAPH was easy to use and contained five relevant and cohesive domains. The items most associated with a desire for dementia screening were male gender, acceptance of other types of screening, and a belief that a treatment for dementia exists.
    Conclusions: Primary care patients in two different health care systems indicated they would like to be screened for dementia. The SAPH was easy to use and contains cohesive domains.
    MeSH term(s) Aged ; Aged, 80 and over ; Attitude to Health ; Cross-Sectional Studies ; Dementia/diagnosis ; Dementia/psychology ; Female ; Humans ; Logistic Models ; Male ; Mass Screening/psychology ; Middle Aged ; Patient Acceptance of Health Care/psychology ; Surveys and Questionnaires
    Language English
    Publishing date 2011-04
    Publishing country England
    Document type Journal Article
    ZDB-ID 806736-3
    ISSN 1099-1166 ; 0885-6230
    ISSN (online) 1099-1166
    ISSN 0885-6230
    DOI 10.1002/gps.2536
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  6. Article ; Online: Genetic structure in patchy populations of a candidate foundation plant: a case study of Leymus chinensis using genetic and clonal diversity.

    Guo, Jian / Richards, Christina L / Holsinger, Kent E / Fox, Gordon A / Zhang, Zhuo / Zhou, Chan

    American journal of botany

    2021  Volume 108, Issue 12, Page(s) 2371–2387

    Abstract: ... multilocus genotypes (MLG), and then by grouping similar MLGs into multilocus lineages. We used 186 markers ... size, and the effect of the number of markers used to evaluate genetic diversity and structure ...

    Abstract Premise: The distribution of genetic diversity on the landscape has critical ecological and evolutionary implications. This may be especially the case on a local scale for foundation plant species because they create and define ecological communities, contributing disproportionately to ecosystem function.
    Methods: We examined the distribution of genetic diversity and clones, which we defined first as unique multilocus genotypes (MLG), and then by grouping similar MLGs into multilocus lineages. We used 186 markers from inter-simple sequence repeats (ISSR) across 358 ramets from 13 patches of the foundation grass Leymus chinensis. We examined the relationship between genetic and clonal diversities, their variation with patch size, and the effect of the number of markers used to evaluate genetic diversity and structure in this species.
    Results: Every ramet had a unique MLG. Almost all patches consisted of individuals belonging to a single multilocus lineages. We confirmed this with a clustering algorithm to group related genotypes. The predominance of a single lineage within each patch could be the result of the accumulation of somatic mutations, limited dispersal, some sexual reproduction with partners mainly restricted to the same patch, or a combination of all three.
    Conclusions: We found strong genetic structure among patches of L. chinensis. Consistent with previous work on the species, the clustering of similar genotypes within patches suggests that clonal reproduction combined with somatic mutation, limited dispersal, and some degree of sexual reproduction among neighbors causes individuals within a patch to be more closely related than among patches.
    MeSH term(s) Ecosystem ; Genetic Variation ; Genotype ; Microsatellite Repeats/genetics ; Plants ; Poaceae ; Reproduction
    Language English
    Publishing date 2021-12-24
    Publishing country United States
    Document type Journal Article ; Research Support, Non-U.S. Gov't
    ZDB-ID 2935-x
    ISSN 1537-2197 ; 0002-9122
    ISSN (online) 1537-2197
    ISSN 0002-9122
    DOI 10.1002/ajb2.1771
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  7. Article ; Online: Stability of Diagnoses of Cognitive Impairment, Not Dementia in a Veterans Affairs Primary Care Population.

    Holsinger, Tracey / Plassman, Brenda L / Stechuchak, Karen M / Burke, James R / Coffman, Cynthia J / Williams, John W

    Journal of the American Geriatrics Society

    2015  Volume 63, Issue 6, Page(s) 1105–1111

    Abstract: Objectives: To describe the stability of cognitive impairment, not dementia (CIND) in a longitudinal cohort of primary care veterans. To examine the association between baseline brief cognitive screening tests, demographic and clinical characteristics, ... ...

    Abstract Objectives: To describe the stability of cognitive impairment, not dementia (CIND) in a longitudinal cohort of primary care veterans. To examine the association between baseline brief cognitive screening tests, demographic and clinical characteristics, and cognitive decline.
    Design: Follow-up cognitive assessment after an average of 2.5 years of a cohort of veterans in primary care whose baseline status was CIND or normal cognition.
    Setting: Three Department of Veterans Affairs primary care clinics.
    Participants: Subjects with CIND at baseline and a sampling of subjects with baseline normal cognition.
    Measurements: Veterans underwent a standard assessment, including neuropsychological tests and informant interview.
    Results: Of 293 potentially eligible individuals, 186 enrolled in the follow-up study. Of the 131 subjects with a baseline diagnosis of CIND, 16 (12%) progressed to dementia, 88 (67%) continued to have a diagnosis of CIND, and 27 (21%) improved to normal cognition. Of the 55 subjects with a baseline diagnosis of normal cognition, one (2%) progressed to dementia, 17 (31%) progressed to CIND, and 37 (67%) remained cognitively normal. In bivariate analyses, poorer performance on baseline cognitive screening tests was associated with cognitive decline, whereas Framingham Stroke Risk Profile (FSRP) and education were not. Similarly, higher scores on cognitive screening tests were associated with return to normal cognition. In multivariable logistic regression models, lower baseline Mini-Cog and Modified Mini-Mental State scores were associated with cognitive decline, whereas Memory Impairment Screen scores, FSRP, and years of education were not.
    Conclusion: A minority of subjects had worsening of cognitive function sufficient to change diagnostic category. Over an average of 2.5 years, subjects diagnosed with CIND at baseline reverted to normal cognition at a higher rate than progressed to dementia. Cognitive screening tests addressing multiple domains of cognitive impairment were predictive of cognitive decline.
    MeSH term(s) Adult ; Cognition Disorders/diagnosis ; Cognition Disorders/epidemiology ; Dementia/diagnosis ; Dementia/epidemiology ; Disability Evaluation ; Female ; Follow-Up Studies ; Humans ; Male ; Mental Health/statistics & numerical data ; Neuropsychological Tests ; Psychiatric Status Rating Scales ; United States/epidemiology ; United States Department of Veterans Affairs ; Veterans/statistics & numerical data
    Language English
    Publishing date 2015-06
    Publishing country United States
    Document type Journal Article ; Research Support, U.S. Gov't, Non-P.H.S.
    ZDB-ID 80363-7
    ISSN 1532-5415 ; 0002-8614
    ISSN (online) 1532-5415
    ISSN 0002-8614
    DOI 10.1111/jgs.13455
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  8. Article: Intelligence in early adulthood and life span up to 65 years later in male elderly twins.

    Holsinger, Tracey / Helms, Michael / Plassman, Brenda

    Age and ageing

    2007  Volume 36, Issue 3, Page(s) 286–291

    Abstract: Background: Previous research has reported that greater intelligence in early life is associated with longer lifespan. Whether this relationship is mediated by genetic factors or environmental factors, some of which could be modified by an individual, ... ...

    Abstract Background: Previous research has reported that greater intelligence in early life is associated with longer lifespan. Whether this relationship is mediated by genetic factors or environmental factors, some of which could be modified by an individual, is unclear.
    Objective: We examined the association between intelligence test scores, obtained during the 1940s, and age at death in a group of 492 male twin pairs, members of the National Academy of Sciences--National Research Council Twins Registry of WWII veterans.
    Design: Using self-report information collected in th 1960s, we examined whether modifiable risk factors for mortality, such as use of tobacco and alcohol, cardiovascular disease, and body mass index altered the association between intelligence and longevity.
    Results: When each member of a twin pair was treated as an independent observation, higher intelligence test scores were associated with longer life span (P = 0.0002). Modifiable risk factors were associated with life span as expected. However, in co-twin control analyses in which one twin served as the control for the other twin, neither intelligence nor any modifiable risk factors showed a significant association with life span.
    Conclusion: Our findings suggest that genetics and early life environmental factors contribute heavily to lifespan and when one controls for these factors using twins, the effect of intelligence on longevity is diminished.
    MeSH term(s) Aged ; Aging/genetics ; Aging/psychology ; Case-Control Studies ; Humans ; Intelligence ; Intelligence Tests ; Kaplan-Meier Estimate ; Longevity/genetics ; Male ; Middle Aged ; Mortality/trends ; Proportional Hazards Models ; Registries ; Twins/genetics ; Twins/physiology ; United States ; Veterans ; World War II
    Language English
    Publishing date 2007-05
    Publishing country England
    Document type Journal Article ; Research Support, N.I.H., Extramural ; Twin Study
    ZDB-ID 186788-x
    ISSN 1468-2834 ; 0002-0729
    ISSN (online) 1468-2834
    ISSN 0002-0729
    DOI 10.1093/ageing/afm016
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  9. Article ; Online: Does this patient have dementia?

    Holsinger, Tracey / Deveau, Janie / Boustani, Malaz / Williams, John W

    JAMA

    2007  Volume 297, Issue 21, Page(s) 2391–2404

    Abstract: Context: While as many as 5 million individuals in the United States have dementia, many others have memory complaints. Brief tests to screen for cognitive impairment could help guide dementia diagnosis.: Objective: To review the literature ... ...

    Abstract Context: While as many as 5 million individuals in the United States have dementia, many others have memory complaints. Brief tests to screen for cognitive impairment could help guide dementia diagnosis.
    Objective: To review the literature concerning the practicality and accuracy of brief cognitive screening instruments in primary care.
    Data sources: A search of MEDLINE (including data from AIDSLINE, BioethicsLine, and HealthSTAR) and psycINFO was conducted from January 2000 through April 2006 to update previous reviews.
    Study selection: Studies of patients aged 60 years and older and use of an acceptable criterion standard to diagnose dementia were considered.
    Data extraction: Studies were assessed by 2 independent reviewers for eligibility and quality. A third independent reviewer adjudicated disagreements. Data for likelihood ratios (LRs) were extracted.
    Data synthesis: Twenty-nine studies using 25 different screening instruments met inclusion criteria; some studies evaluated several different instruments, thus, information could be examined for 38 unique instrument/study combinations.
    Results: For the commonly used Mini-Mental State Examination, the median LR for a positive result was 6.3 (95% confidence interval [CI], 3.4-47.0) and the median LR for a negative result was 0.19 (95%CI, 0.06-0.37). Briefer approaches are available but have not been studied as frequently. Reports from an informant that the patient has memory loss yields an LR of 6.5 (95% CI, 4.4-9.6) for dementia. The Memory Impairment Screen takes 4 minutes to ask 4 items and has an LR for a positive result of 33 (95% CI, 15.0-72.0) and an LR for a negative result is 0.08 (95% CI, 0.02-0.3). Clock drawings are helpful in 1- to 3-minute forms, but must be scored appropriately and sensitivity to mild forms of impairment can be low.
    Conclusions: Clinicians should select 1 primary tool based on (1) the population receiving care; (2) an awareness of the effects of educational level, race, and age on scoring; and (3) consideration of adding 1 or 2 other tools for special situations as needed.
    MeSH term(s) Dementia/diagnosis ; Diagnosis, Differential ; Humans ; Memory Disorders/diagnosis ; Mental Status Schedule ; Neurocognitive Disorders/diagnosis ; Neuropsychological Tests
    Language English
    Publishing date 2007-06-06
    Publishing country United States
    Document type Journal Article ; Research Support, N.I.H., Extramural ; Research Support, U.S. Gov't, Non-P.H.S. ; Review
    ZDB-ID 2958-0
    ISSN 1538-3598 ; 0254-9077 ; 0002-9955 ; 0098-7484
    ISSN (online) 1538-3598
    ISSN 0254-9077 ; 0002-9955 ; 0098-7484
    DOI 10.1001/jama.297.21.2391
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  10. Article ; Online: Systematic review: factors associated with risk for and possible prevention of cognitive decline in later life.

    Plassman, Brenda L / Williams, John W / Burke, James R / Holsinger, Tracey / Benjamin, Sophiya

    Annals of internal medicine

    2010  Volume 153, Issue 3, Page(s) 182–193

    Abstract: Background: Many biological, behavioral, social, and environmental factors may contribute to the delay or prevention of cognitive decline.: Purpose: To summarize evidence about putative risk and protective factors for cognitive decline in older ... ...

    Abstract Background: Many biological, behavioral, social, and environmental factors may contribute to the delay or prevention of cognitive decline.
    Purpose: To summarize evidence about putative risk and protective factors for cognitive decline in older adults and the effects of interventions for preserving cognition.
    Data sources: English-language publications in MEDLINE, HuGEpedia, AlzGene, and the Cochrane Database of Systematic Reviews from 1984 through 27 October 2009.
    Study selection: Observational studies with 300 or more participants and randomized, controlled trials (RCTs) with 50 or more adult participants who were 50 years or older, drawn from general populations, and followed for at least 1 year were included. Relevant, good-quality systematic reviews were also eligible.
    Data extraction: Information on study design, outcomes, and quality were extracted by one researcher and verified by another. An overall rating of the quality of evidence was assigned by using the GRADE (Grading of Recommendations Assessment, Development, and Evaluation) criteria.
    Data synthesis: 127 observational studies, 22 RCTs, and 16 systematic reviews were reviewed in the areas of nutritional factors; medical factors and medications; social, economic, or behavioral factors; toxic environmental exposures; and genetics. Few of the factors had sufficient evidence to support an association with cognitive decline. On the basis of observational studies, evidence that supported the benefits of selected nutritional factors or cognitive, physical, or other leisure activities was limited. Current tobacco use, the apolipoprotein E epsilon4 genotype, and certain medical conditions were associated with increased risk. One RCT found a small, sustained benefit from cognitive training (high quality of evidence) and a small RCT reported that physical exercise helps to maintain cognitive function.
    Limitations: The categorization and definition of exposures were heterogeneous. Few studies were designed a priori to assess associations between specific exposures and cognitive decline. The review included only English-language studies, prioritized categorical outcomes, and excluded small studies.
    Conclusion: Few potentially beneficial factors were identified from the evidence on risk or protective factors associated with cognitive decline, but the overall quality of the evidence was low.
    Primary funding source: Agency for Healthcare Research and Quality and the National Institute on Aging, through the Office of Medical Applications of Research, National Institutes of Health.
    MeSH term(s) Aged ; Alzheimer Disease/complications ; Alzheimer Disease/etiology ; Alzheimer Disease/prevention & control ; Cognition Disorders/etiology ; Cognition Disorders/prevention & control ; Cognition Disorders/therapy ; Evidence-Based Medicine ; Humans ; Middle Aged ; Risk Factors ; Risk Reduction Behavior
    Language English
    Publishing date 2010-08-03
    Publishing country United States
    Document type Journal Article ; Research Support, N.I.H., Extramural ; Research Support, Non-U.S. Gov't ; Research Support, U.S. Gov't, Non-P.H.S. ; Research Support, U.S. Gov't, P.H.S. ; Review
    ZDB-ID 336-0
    ISSN 1539-3704 ; 0003-4819
    ISSN (online) 1539-3704
    ISSN 0003-4819
    DOI 10.7326/0003-4819-153-3-201008030-00258
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

To top